Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis

Tom Pembroke(Royal Victoria Regional Health Centre), Giada Sebastiani(McGill University Health Centre), Peter Ghali(Royal Victoria Regional Health Centre), Élise Vuille‐Lessard(Royal Victoria Regional Health Centre), Amine Benmassaoud(Royal Victoria Regional Health Centre), Marc Deschênes(Royal Victoria Regional Health Centre), Bertrand Lebouché(Royal Victoria Regional Health Centre), Maida Sewitch(Royal Victoria Regional Health Centre), Costa Pexos(Royal Victoria Regional Health Centre), Philip Wong(University of California, Santa Barbara), Marina B. Klein(McGill University), Alex S. Halme(Royal Victoria Regional Health Centre)
Journal of Hepatology
May 18, 2017
10.1016/j.jhep.2017.05.011
Cited by 94

Related Papers

Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
|Hepatology|2014|2k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada
|AIDS Research and Human Retroviruses|2015|335
Predictive Accuracy of the Veterans Aging Cohort Study Index for Mortality With HIV Infection
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2012|219
Cohort Profile: The North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)
|International Journal of Epidemiology|2007|212